Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Exane BNP Paribas Upgrades Medical Properties Trust to Outperform, Announces $6 Price Target

Author: Benzinga Newsdesk | March 01, 2024 12:08pm
Exane BNP Paribas analyst Nate Crossett upgrades Medical Properties Trust (NYSE:MPW) from Neutral to Outperform and announces $6 price target.

Posted In: MPW

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist